Recent Updates
Recently added Catalysts

Lopressor

Phase 1

Healthy | Small molecule | Other |Viatris Inc.|Last Updated: Apr 23, 2024

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedACTIVE_CONTROLLEDBiomarker
Total Trials2
Total Enrollment39

FDA Designations

No designations recorded

Clinical trial landscape

Lopressor · 2 trials · 1 indication

Phase 1 2
NCT00648271Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mgHealthy
COMPLETED19 Analytics
NCT00649116Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mgHealthy
COMPLETED20 Analytics
PHASE1COMPLETED
Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg
HealthyUnlock trial analytics
PHASE1COMPLETED
Fed Study of Metoprolol Tartrate Tablets 100 mg and Lopressor® 100 mg
HealthyUnlock trial analytics

Study Endpoints

Primary Endpoints

Bioequivalence
within 30 days
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingNONE
ModelCROSSOVER
PurposeOTHER

Treatment Arms

ArmTypeDescription
1EXPERIMENTALMetoprolol Tartrate Tablets 25 mg
2ACTIVE_COMPARATORLopressor® Tablets 50 mg

Interventions

NameTypeDescription
Metoprolol Tartrate Tablets 25 mgDRUG2x50mg, single dose fed
Lopressor® Tablets 50 mgDRUG1x50mg, single dose fed
Metoprolol Tartrate Tablets 100 mgDRUG100mg, single dose fed
Lopressor® Tablets 100 mgDRUG100mg, single dose fed
Unlock Study Design Details

Eligibility Criteria

Age Range18 Years to N/A
SexALL
Healthy VolunteersYes
Study Sites1

Inclusion Criteria: 1. Age: 18 years and older. 2. Sex: Male and non-pregnant, non-lactating female 1. Women of childbearing potential must have negative serum beta-human chorionic gonadotropin (HCG) pregnancy tests performed within 14 days prior to the start of the study and the evening prior ...

Countries:United States
Unlock Eligibility Criteria

Frequently asked questions about Lopressor

What is Lopressor used for?

Lopressor is a small molecule drug being developed by Viatris Inc. (VTRS). It is currently in Phase 1 clinical trials for use in healthy volunteers. The drug is being studied in bioavailability and fed-state studies to compare different tablet strengths.

Who makes Lopressor?

Lopressor is developed by Viatris Inc., a global healthcare company traded on the NASDAQ under the ticker VTRS. The company is conducting Phase 1 clinical trials to evaluate the drug's pharmacokinetics in healthy subjects.

What phase is Lopressor in?

Lopressor is in Phase 1 clinical development. It is an investigational drug, meaning it has not yet been approved by regulatory authorities. Two Phase 1 studies have been completed, with no active trials currently ongoing.

What clinical trials is Lopressor in?

Lopressor has two completed Phase 1 clinical trials: NCT00648271, a fed study comparing metoprolol tartrate tablets 25 mg to Lopressor 50 mg, and NCT00649116, a fed study comparing metoprolol tartrate tablets 100 mg to Lopressor 100 mg. Both enrolled healthy adults in the United States.

Is Lopressor the same as metoprolol tartrate?

Lopressor is a brand name for metoprolol tartrate. The clinical trials compare Lopressor to generic metoprolol tartrate tablets to assess bioequivalence under fed conditions. The studies enrolled healthy volunteers aged 18 years and older.